Maze Therapeutics, Inc. (MAZE) Earnings
Maze Therapeutics, Inc. is expected to report next earnings on November 5, 2026 (in NaN days), with a consensus EPS estimate of $-0.79. MAZE has beaten EPS estimates in 2 of its last 5 reported quarters (average surprise +2.8% over the last four).
Next earnings
Nov 5, 2026in NaN days
EPS est $-0.79 · Revenue est $333333
Track record
Beat EPS in 2 of 5 quarters
Avg surprise +2.8% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Aug 12, 2026 | $-0.72 | $-0.76 | -6.0% | — | — |
| May 12, 2026 | $-0.43 | $-0.45 | -4.7% | $20M | +88.2% |
| Mar 25, 2026 | $-0.73 | $-0.65 | +11.0% | — | — |
| Nov 6, 2025 | $-0.74 | $-0.66 | +10.8% | — | — |
| Mar 31, 2025 | $0.45 | $-18.32 | -4171.1% | — | — |
| Sep 30, 2024 | — | $-0.57 | — | $3M | — |
| Jun 30, 2024 | — | $3.18 | — | $165M | — |
| Mar 31, 2024 | — | $-0.74 | — | — | — |
| Dec 31, 2023 | — | $-0.61 | — | — | — |
| Sep 30, 2023 | — | $-0.57 | — | — | — |
Source: company filings + earnings calendar. For informational purposes only — not investment advice.